Skip to content

Baxter International BAX Front Line Care — Net Sales

Other product segments

Infusion Therapies & Technologies
$981M-1.3%
Care & Connectivity Solutions
$435M+1.9%
Drug Compounding
$320M+30.1%
Advanced Surgery
$304M+13.4%
Injectables & Anesthesia
$301M-10.1%

Similar metrics at other companies

Zebra Technologies logo
ZBRACF — Total Net sales
$825M+20.6%
STERIS logo
STEGB — Revenue
$14.2M+17.7%
Nordson logo
NDSNMedical and Fluid Solutions — Sales
$212.85M+5.0%
Fortive logo
FTVMedical technologies — Sales
$308.1M+12.4%
STERIS logo
STEHealthcare [Member] — Revenue
$976.04M+6.5%
DuPont de Nemours, Inc. logo
DDHealthcare Technologies — Net Sales
$467M+11.5%

Other financials

Income statement

See full
Revenue$2.7B+2.9%
Gross profit$891.0M+3.5%
Operating income$66.0M+13.8%
Net income-$15.0M-112%
EPS (diluted)-$0.03-112%

Balance sheet

See full
Cash & equivalents$2.0B-12.1%
Total debt$224.0M-8.9%
Total equity$6.0B-14.7%
Total assets$19.8B-6.8%

Cash flow

See full
Operating cash flow$213.0M+210%
CapEx$128.3M+15.0%
Free cash flow$83.0M-42.1%

Valuation

See full
Market cap$10.27B-50.6%
Enterprise value$8.48B-55.6%
P/S0.9×-1.0×

Profitability

See full
Gross margin30.1%-5.9pp
Operating margin-2.7%
Net margin-9.7%+62.5pp
FCF margin3%-2.4pp

Returns & leverage

See full
Return on equity-16.7%-76.7pp
Debt / equity0.0×
Current ratio1.9×-0.2×

Where this comes from

Reported directly by Baxter International in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The official record: Baxter International’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Baxter International's front line care — net sales.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Baxter International's front line care — net sales?
Baxter International (BAX) reported front line care — net sales of $270M in Q1 2026.
How has Baxter International's front line care — net sales changed year-over-year?
Baxter International's front line care — net sales decreased by 2.5% year-over-year, from $277M to $270M.
What is the long-term trend for Baxter International's front line care — net sales?
Over 4 years (2021 to 2025), Baxter International's front line care — net sales has grown at a 101.8% compound annual growth rate (CAGR), from $70M to $1.16B.
What does front line care — net sales mean?
The total revenue earned from the sale of Front Line Care medical products and services.
How do you interpret front line care — net sales?
An increase indicates growing market adoption and demand for the segment's medical equipment, while a decrease may signal competitive pressure or reduced hospital capital spending.
How does front line care — net sales compare across companies?
Comparable to revenue metrics for medical device segments focused on hospital capital equipment at peer companies.